Strata Skin Sciences Price to Book Ratio 2010-2023 | SSKN
Historical price to book ratio values for Strata Skin Sciences (SSKN) over the last 10 years. The current price to book ratio for Strata Skin Sciences as of May 07, 2024 is 1.14.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Strata Skin Sciences Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2024-05-07 | 0.41 | 1.13 | |
| 2023-12-31 | 0.55 | $0.36 | 1.52 |
| 2023-09-30 | 0.60 | $0.46 | 1.28 |
| 2023-06-30 | 0.95 | $0.48 | 1.96 |
| 2023-03-31 | 1.06 | $0.55 | 1.91 |
| 2022-12-31 | 0.79 | $0.63 | 1.26 |
| 2022-09-30 | 0.87 | $0.63 | 1.39 |
| 2022-06-30 | 0.96 | $0.64 | 1.49 |
| 2022-03-31 | 1.47 | $0.68 | 2.15 |
| 2021-12-31 | 1.47 | $0.74 | 1.98 |
| 2021-09-30 | 1.84 | $0.76 | 2.42 |
| 2021-06-30 | 1.56 | $0.76 | 2.05 |
| 2021-03-31 | 1.67 | $0.71 | 2.34 |
| 2020-12-31 | 1.50 | $0.77 | 1.96 |
| 2020-09-30 | 1.35 | $0.77 | 1.76 |
| 2020-06-30 | 1.15 | $0.79 | 1.45 |
| 2020-03-31 | 0.95 | $0.83 | 1.14 |
| 2019-12-31 | 2.08 | $0.87 | 2.39 |
| 2019-09-30 | 2.15 | $0.88 | 2.45 |
| 2019-06-30 | 2.49 | $0.90 | 2.78 |
| 2019-03-31 | 2.85 | $0.97 | 2.93 |
| 2018-12-31 | 2.60 | $1.04 | 2.49 |
| 2018-09-30 | 3.54 | $1.11 | 3.18 |
| 2018-06-30 | 2.05 | $1.12 | 1.83 |
| 2018-03-31 | 1.17 | $4.52 | 0.26 |
| 2017-12-31 | 1.23 | $4.62 | 0.27 |
| 2017-09-30 | 1.77 | $9.65 | 0.18 |
| 2017-06-30 | 2.43 | $4.69 | 0.52 |
| 2017-03-31 | 3.03 | $5.77 | 0.52 |
| 2016-12-31 | 2.20 | $6.79 | 0.32 |
| 2016-09-30 | 2.65 | $7.40 | 0.36 |
| 2016-06-30 | 3.05 | $8.14 | 0.37 |
| 2016-03-31 | 4.73 | $7.16 | 0.66 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.015B | $0.033B |
| Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $36.426B | 20.00 |
| Inspire Medical Systems (INSP) | United States | $7.603B | 0.00 |
| Axonics (AXNX) | United States | $3.448B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.323B | 0.00 |
| 10x Genomics (TXG) | United States | $3.247B | 0.00 |
| Azenta (AZTA) | United States | $3.087B | 251.59 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.879B | 0.00 |
| Enovis (ENOV) | United States | $2.793B | 20.70 |
| Hims & Hers Health (HIMS) | United States | $2.496B | 0.00 |
| Privia Health (PRVA) | United States | $2.264B | 100.42 |
| Schrodinger (SDGR) | United States | $1.739B | 0.00 |
| Omnicell (OMCL) | United States | $1.377B | 47.59 |
| Phreesia (PHR) | United States | $1.279B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.865B | 0.00 |
| Standard BioTools (LAB) | United States | $0.719B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.643B | 0.00 |
| Talkspace (TALK) | United States | $0.539B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.410B | 0.00 |
| Pulmonx (LUNG) | United States | $0.360B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.357B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.329B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.229B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.202B | 0.00 |
| Outset Medical (OM) | United States | $0.196B | 0.00 |
| American Well (AMWL) | United States | $0.164B | 0.00 |
| Augmedix (AUGX) | United States | $0.132B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.124B | 0.00 |
| TruBridge (TBRG) | United States | $0.119B | 5.07 |
| 111 (YI) | China | $0.097B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.081B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.074B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| Zepp Health (ZEPP) | China | $0.055B | 0.00 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.047B | 0.00 |
| Movano (MOVE) | United States | $0.045B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
| Akili (AKLI) | United States | $0.033B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.024B | 0.00 |
| Cue Health (HLTH) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| CareCloud (CCLD) | United States | $0.017B | 0.00 |
| ETAO (ETAO) | United States | $0.016B | 0.00 |
| Biotricity (BTCY) | United States | $0.011B | 0.00 |
| Syra Health (SYRA) | United States | $0.010B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |